CN Patent

CN102596252A — 用于对乙酰氨基酚的立即和延长释放的胃滞留药物组合物

Assigned to Assertio Holdings Inc · Expires 2012-07-18 · 14y expired

What this patent protects

描述了用于对乙酰氨基酚的延长释放或用于对乙酰氨基酚的立即和延长释放的胃滞留剂型。该剂型允许在每天一次或2次给药后的有效疼痛缓解。还描述了使用剂型的治疗方法和制备剂型的方法。

USPTO Abstract

描述了用于对乙酰氨基酚的延长释放或用于对乙酰氨基酚的立即和延长释放的胃滞留剂型。该剂型允许在每天一次或2次给药后的有效疼痛缓解。还描述了使用剂型的治疗方法和制备剂型的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102596252A
Jurisdiction
CN
Classification
—
Expires
2012-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Assertio Holdings Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.